LIVINGSTON, NJ--(Marketwired - February 06, 2015) - Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Monday, February 9th at 11:00 a.m. EST at The Brewer Group Innovations Conference. The conference is being held at the Mondrian South Beach in Miami, Florida.
The Innovations Conference is hosted by The Brewer Group, Inc. (TBG), an industry agnostic holding company with assets ranging across numerous sectors. The conference represents an opportunity for small cap, middle market and emerging private and public companies to showcase their products, services and programs. It is a new venue for experts and investors to collaborate, exchange research and wisdom and take advantage of an intellectually diverse environment to evolve ideas in multiple fields. For more information please visit www.thebrewergroup.com.
About Milestone Scientific Inc.
Milestone Scientific Inc. is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2013. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.